Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
US Stock MarketDetailed Quotes
SABS SAB Biotherapeutics
- 3.7942
- -0.3558-8.57%
Close Dec 31 16:00 ET
35.02MMarket Cap-0.60P/E (TTM)
4.0500High3.7501Low48.85KVolume4.0500Open4.1500Pre Close188.33KTurnover0.80%Turnover RatioLossP/E (Static)9.23MShares6.390052wk High0.95P/B23.22MFloat Cap2.160052wk Low--Dividend TTM6.12MShs Float129.0000Historical High--Div YieldTTM7.23%Amplitude2.1600Historical Low3.8550Avg Price1Lot Size
SAB Biotherapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 31, 2024
The average SAB Biotherapeutics stock price target is 9.67 with a max estimate of 12.00 and a min estimate of 6.00
Review SAB Biotherapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 31, 2024